Table 3 Endometrial tissues survivin, ER, and PR expression before and after treatment in the control group
Pathology before treatment | n | Before treatment (mean ± SD) | After treatment (mean ± SD) | ||||
|---|---|---|---|---|---|---|---|
Survivin scores | ER (%) | PR (%) | Survivin scores | ER (%) | PR (%) | ||
Proliferative endometrium | 8 | 5.5 ± 1.2 | 53.3 ± 18.1 | 40.6 ± 27.3 | 5.7 ± 1.8 | 55.6 ± 30.1 | 51.8 ± 37.0 |
Simple hyperplasia | 14 | 6.1 ± 1.8 | 58.1 ± 16.3 | 44.7 ± 262 | 5.9 ± 1.6 | 57.6 ± 34.3 | 50.7 ± 30.1 |
Complex hyperplasia | 10 | 8.5 ± 2.0 | 86.2 ± 36.2 | 85.3 ± 21.5 | 6.7 ± 2.3 | 82.7 ± 32.1 | 77.1 ± 36.4 |